Randomized controlled trials in the West African Ebola virus outbreak

Abstract

Get full access to this article

View all access options for this article.

References

World Health Organization. Ethical considerations for use of unregistered interventions for Ebola virus disease. Report of an advisory panel to WHO, http://www.who.int/csr/resources/publications/ebola/ethical-considerations/en/ (2014, accessed 9 September 2015).

Cox

Borio

Temple

. Evaluating Ebola therapies—the case for RCTs. N Engl J Med 2014; 371: 2350–2351.

Rid

Emanuel

. Ethical considerations of experimental interventions in the Ebola outbreak. Lancet 2014; 384: 1896–1899.

National Institute of Allergy and Infectious Diseases, National Institutes of Health. Questions and answers. PREVAIL phase 2/3 clinical trial of investigational Ebola vaccines, http://www.niaid.nih.gov/news/QA/Pages/EbolaVaxresultsQA.aspx (2015, accessed 9 September 2015).

Caplan

Plunkett

Levin

. Selecting the right tool for the job. Am J Bioeth 2015; 15: 4–10.

Adebamowo

Bah-Sow

Binka

. Randomised controlled trials for Ebola: practical and ethical issues. Lancet 2014; 384: 1423–1424.

Jones

Podolsky

. The history and fate of the gold standard. Lancet 2015; 385: 1502–1503.

Cartwright

Munro

. The limitations of randomized controlled trials in predicting effectiveness. J Eval Clin Pract 2010; 16: 260–266.

Cartwright

. A philosopher’s view of the long road from RCTs to effectiveness. Lancet 2011; 377: 1400–1401.

10.

Worrall

. What evidence in evidence-based medicine? Philos Sci 2002; 69: S316–S330.

11.

La Caze

Djulbegovic

Senn

. What does randomisation achieve? Evid Based Med 2012; 17: 1–2.

12.

Yusuf

Collins

Peto

. Why do we need some large, simple randomized trials? Stat Med 1984; 3: 409–422.

13.

World Health Organization. Ethical issues related to study design for trials on therapeutics for Ebola virus disease. In: WHO Ethics Working Group meeting, http://www.who.int/csr/resources/publications/ebola/ethical-evd-therapeutics/en/ (2014, accessed 9 September 2015).

14.

Henao-Restrepo

Longini

Egger

. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015; 386: 857–866.

15.

Hill

. The philosophy of the clinical trial. In: Statistical methods in clinical and preventive medicine. Edinburgh: E&S Livingston, 1962, p6.